Effective analysis of Lizhuchangle combined trimebutine maleate on treating irritable bowel syndrome
Rong Wang
Abstract
Rong Wang
Abstract
Objective:To observe the efficacy of Lizhuchangle combined with trimebutine maleate on the treatment for irritable bowel syndrome(IBS).Methods:135 cases of IBS were randomly divided into two groups.The treatment group was given Lizhuchangle and trimebutine maleate,while the control group was given trimebutine maleate for 4 weeks.Results:The total effective rates were 88.57% for the treatment group and 73.85% for the control group respectively.The therapeutic effects of the treatment group was better than that of the control group(P0.05).The 6-month recurrence rate in the treatment group showed significant difference compared with that in the control group(P0.05).Conclusion:Lizhuchangle combined with trimebutine maleate has good clinical effect in the treatment of IBS with low recurrence rate,which is superior to single use of trimebutine maleate and worthy of promotion and application in clinic.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the efficacy of Lizhuchangle combined with trimebutine maleate on the treatment for irritable bowel syndrome(IBS).Methods:135 cases of IBS were randomly divided into two groups.The treatment group was given Lizhuchangle and trimebutine maleate,while the control group was given trimebutine maleate for 4 weeks.Results:The total effective rates were 88.57% for the treatment group and 73.85% for the control group respectively.The therapeutic effects of the treatment group was better than that of the control group(P0.05).The 6-month recurrence rate in the treatment group showed significant difference compared with that in the control group(P0.05).Conclusion:Lizhuchangle combined with trimebutine maleate has good clinical effect in the treatment of IBS with low recurrence rate,which is superior to single use of trimebutine maleate and worthy of promotion and application in clinic.
Key concepts: Medicine, Irritable bowel syndrome, Internal medicine, Clinical efficacy, Gastroenterology, Treatment and control groups, Anesthesia